2,3-dihydro-1H-benzo[de]isoquinolin-1-one | 18833-41-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: 2,3-dihydro-1H-benzo[de]isoquinolin-1-one
• 英文别名: 2-Aza-2,3-dihydro-phenalon；2,3-dihydro-benzo[de]isoquinolin-1-one；2,3-dihydro-1H-benz[de]isoquinolin-1-one radical；2,3-dihydro-1H-benz[de]isoquinolin-1-one；2,3-Dihydro-benzo[de]isoquinolin-1-one；2,3-dihydrobenzo[de]isoquinolin-1-one
• CAS: 18833-41-5
• 化学式: C₁₂H₉NO
• mdl: MFCD03265285
• 分子量: 183.21
• InChiKey: QGJHNXPHHOCUAH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.083
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  萘亚胺 在 sodium tetrahydroborate 作用下， 以 乙醇 、 水 为溶剂， 反应 24.0h， 以97%的产率得到2,3-dihydro-1H-benzo[de]isoquinolin-1-one
  参考文献：
  名称：

  New and Convenient Synthesis of 2-Substituted 2,3-Dihydro-1H-benz[de]isoquinolin-1-ones

  摘要：

  通过在室温下使用钠或锌氢化硼对2-取代的1H-benz[de]isoquinoline-1,3(2H)-二酮进行化学选择性还原，获得了多种2-取代的2,3-二氢-1H-benz[de]isoquinolin-1-酮，产率很高。

  DOI：

  10.1246/bcsj.61.2238

文献信息

• Integrated Experimental and Computational Studies on the Organocatalytic Kinetic Resolution of β-Unfunctionalized Primary Alcohols Using a Chiral 1,2-Diamine: The Importance of Noncovalent Interactions
  作者：Naoki Sakai、Kohei Ojima、Seiji Mori、Takeshi Oriyama

  DOI：10.1021/acs.joc.1c03033

  日期：2022.3.18

  The enantioselective kinetic resolution of β-unfunctionalized primary alcohols with benzoyl chloride was carried out in the presence of a catalytic amount of a novel chiral 1,2-diamine derived from (S)-proline. Several valuable chiral 2-substituted propan-1-ols were obtained with good enantioselectivities. Density functional theory calculations revealed that the noncovalent interaction, such as CH−π

  β-非官能化伯醇与苯甲酰氯的对映选择性动力学拆分是在催化量的衍生自 ( S )-脯氨酸的新型手性 1,2-二胺存在下进行的。获得了几种有价值的手性 2-取代丙-1-醇，具有良好的对映选择性。密度泛函理论计算表明，非共价相互作用，例如 CH-π 相互作用，对于分辨率的对映选择性至关重要。这项研究是通过实验和计算之间的相互作用进行的。
• METHODS AND COMPOSITIONS FOR TREATING BETA-THALASSEMIA AND SICKLE CELL DISEASE
  申请人：ACADEMIA SINICA

  公开号：US20160106728A1

  公开（公告）日：2016-04-21

  Compounds, pharmaceutical compositions, and methods for treating anemia β-thalassemia anemia or sickle cell anemia.

  化合物、药物组合和治疗贫血β-地中海贫血或镰状细胞贫血的方法。
• Methods of modulating neurotrophin-mediated activity
  申请人：Babinski Kazimierz

  公开号：US20070093474A1

  公开（公告）日：2007-04-26

  Disclosed are compositions which modulate the interaction with nerve growth factor and precursors thereof with neurotrophic receptors. Also disclosed are methods of using the compositions of the invention, including methods of administration.

  本发明涉及一种调节神经生长因子及其前体与神经营养受体相互作用的组合物。本发明还涉及使用该组合物的方法，包括给药方法。
• Pigment dispersion, and ink composition, curable composition and curable ink composition produced with pigment dispersion
  申请人：Fujifilm Corporation

  公开号：EP2233537A1

  公开（公告）日：2010-09-29

  The present invention provides a pigment dispersion, including: (a) a pigment; and (b) a polymer compound as a dispersant for the pigment (a), wherein the polymer compound includes a urethane bond in a main chain, includes a pendant moiety containing a skeleton which is the same as a partial skeleton of the pigment (a), and further includes, at a side chain, at least one polymer chain selected from the group consisting of a polyester chain, a poly(meth)acrylate chain, and a polyalkylene oxide chain, and wherein the molecular weight of the skeleton which is the same as a partial skeleton of the pigment (a) is from 20 to 70% of the molecular weight of the pigment (a).

  本发明提供了一种颜料分散体，包括(a) 颜料(b) 作为颜料（a）分散剂的聚合物化合物，其中聚合物化合物在主链中包括一个氨基甲酸酯键，包括一个含有与颜料（a）的部分骨架相同的骨架的悬垂分子，并在侧链中进一步包括至少一条聚合物链，选自由聚酯链、聚（甲基）丙烯酸酯链和聚环氧烷链组成的组，其中与颜料（a）部分骨架相同的骨架的分子量为颜料（a）分子量的 20% 至 70%。
• Dna damage repair inhibitors for treatment of cancer
  申请人：Kudos Pharmaceuticals Limited

  公开号：EP2305221A1

  公开（公告）日：2011-04-06

  The present invention relates to the recognition that inhibition of the base excision repair pathway is selectively lethal in cells which are deficient in HR dependent DNA DSB repair. Methods and means relating to the treatment of cancers which are deficient in HR dependent DNA DSB repair using inhibitors which target base excision repair components, such as PARP, is provided herein.

  本发明涉及一种认识，即抑制碱基切除修复途径对缺乏 HR 依赖性 DNA DSB 修复的细胞具有选择性致死作用。本发明提供了使用靶向碱基切除修复成分（如 PARP）的抑制剂治疗缺乏 HR 依赖性 DNA DSB 修复的癌症的方法和手段。